Elderberry supplementation may reduce the duration and severity of upper respiratory symptoms, according to a meta-analysis published in the journal Complementary Therapies in Medicine.
Regeneron and Sanofi announced that the Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled severe chronic rhinosinusitis with nasal polyps (CRSwNP). The sBLA included data from two phase 3 randomized, double-blind, placebo-controlled trials (SINUS-24…
Recommendations have been developed for home oxygen therapy in children with chronic respiratory conditions; the clinical practice guideline from the American Thoracic Society was published in the February 1 issue of the American Journal of Respiratory and Critical Care Medicine.
Children with asthma who received montelukast had no increased risk for neuropsychiatric disease compared with children who did not receive the treatment.
Researchers sought to determine whether a multidisciplinary SABA reduction program would significantly increase the percentage of patients who reached an AMR ≥0.5.
Quality of sleep significantly improved in patients with allergic rhinitis who were treated with the house dust mite (HDM) sublingual immunotherapy-tablet (12 SQ-HDM), according to a post hoc analysis.
Asthma is linked to osteopenia, osteoporosis, osteomalacia, and pathological fractures in the United States.
Patients with chronic rhinosinusitis with nasal polyps experienced improvements in endoscopic, radiologic, and clinical outcomes when treated with dupilumab as add-on therapy to intranasal mometasone furoate.
Treatment with the humanized anti-interleukin-5 monoclonal antibody reslizumab has been associated with clinically meaningful improvements in asthma control and quality of life.
Dupilumab is generally well tolerated and improves health-related quality of life associated with rhinoconjunctivitis in patients with uncontrolled moderate to severe asthma with comorbid allergic rhinitis.
